However, as expected, anti-SIRPα treatment also exacerbated anemia during SAA by 14 dpst (Supplementary Fig. 9F-I), consistent with the role of CD47 as an important “marker of self” on healthy cells, especially red blood cells [41]. This evidence concerns the gene SIRPA and anemia.